The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Laranjeira Charles Anthony since 2013.
This trader's CIK number is 1524338.
At the time of last reporting, Laranjeira Charles Anthony was the Chief Technical Officer of Pacira Biosciences, Inc.. (stock ticker symbol PCRX).
Also see all insider trading activities at Pacira Biosciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | CBST | 0 | $0 | 14,384 | $750,897 | 15,000 | $531,482 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | PCRX | 0 | $0 | 7,750 | $471,679 | 6,000 | $230,100 |
| 2021 | PCRX | 0 | $0 | 0 | $0 | 7,500 | $330,750 |
| 2020 | PCRX | 0 | $0 | 63,464 | $3,253,061 | 58,750 | $2,413,687 |
| 2019 | PCRX | 0 | $0 | 430 | $18,451 | 0 | $0 |
1. Cubist Pharmaceuticals Inc (CBST)
2. Pacira Biosciences, Inc. (PCRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-05-20 | CBST | Option Ex | 14,000 | 37.96 | 531,482 |
| 2013-05-20 | CBST | Sale | 14,000 | 52.50 | 735,000 |
| 2013-02-16 | CBST | Option Ex | 1,000 | .00 | 0 |
| 2013-02-19 | CBST | Sale | 384 | 41.40 | 15,897 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-14 | PCRX | Option Ex | 6,000 | 38.35 | 230,100 |
| 2022-06-06 | PCRX | Sale | 2,813 | 61.37 | 172,645 |
| 2022-06-08 | PCRX | Sale | 4,937 | 60.57 | 299,034 |
| 2021-11-22 | PCRX | Option Ex | 7,500 | 44.10 | 330,750 |
| 2020-08-03 | PCRX | Sale | 2,500 | 52.68 | 131,700 |
| 2020-08-03 | PCRX | Option Ex | 2,500 | 44.10 | 110,250 |
| 2020-06-29 | PCRX | Option Ex | 56,250 | 40.95 | 2,303,437 |
| 2020-06-29 | PCRX | Sale | 60,101 | 51.27 | 3,081,378 |
| 2020-06-04 | PCRX | Sale | 863 | 46.33 | 39,983 |
| 2019-06-04 | PCRX | Sale | 430 | 42.91 | 18,451 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Laranjeira Charles Anthony (Chief Technical Officer of Pacira Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.